While NRF2 has a protective role in normal cells, including the prevention of the initiation of carcinogenesis, once cancer is already initiated, NRF2 reveals its dark side by protecting cancer cells from chemo- and radiotherapy, resulting in an increased activity of NRF2, which is linked to poorer prognosis in several types of cancer. Here, NFE2L2 is linked to cancer.